Linda Burkly - Dec 3, 2025 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Signature
/s/ Linda C. Burkly
Stock symbol
EDIT
Transactions as of
Dec 3, 2025
Transactions value $
-$1,535
Form type
4
Date filed
12/4/2025, 04:39 PM
Previous filing
Sep 4, 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER 11 HURLEY ST., CAMBRIDGE /s/ Linda C. Burkly 2025-12-04 0001985604

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Sale -$1.54K -713 -1.03% $2.15 68.8K Dec 3, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person.